Target Information

Content Navigation (  All   None )                                      
Target General Information
Drugs and Modes of Action
Drug Binding Sites of Target
Different Human System Profiles of Target
Chemical Structure based Activity Landscape of Target
Drug Property Profile of Target
Co-Targets
Target Poor or Non Binders
Target Regulators
Target Profiles in Patients
Target Affiliated Biological Pathways
Target-Related Models and Studies
References
Drug Binding Sites of Target  Top
Ligand Name: Arachidonic acid Ligand Info
Structure Description S663D Stable-5-LOX in complex with Arachidonic Acid PDB:3V99
Method X-ray diffraction Resolution 2.25 Å Mutation Yes [161]
PDB Sequence
SYTVTVATGS
14
QEHAGTDDYI
24
YLSLVGSAGC
34
SEKHLLDKGS
44
FERGAVDSYD
54

VTVDEELGEI
64
QLVRIEKRKY
74
GSNDDWYLKY
84
ITLKTPHGDY
94
IEFPCYRWIT
104

GDVEVVLRDG
114
RAKLARDDQI
124
HILKQHRRKE
134
LETRQKQYRW
144
MEWNPGFPLS
154

IDAKCHKDLP
164
RDIQFDSFVL
179
NYSKAMENLF
189
QSSWNDFADF
207
EKIFVKISNT
217

ISERVMNHWQ
227
EDLMFGYQFL
237
NGANPVLIRR
247
CTELPEKLPV
257
TTEMVECSLE
267

RQLSLEQEVQ
277
QGNIFIVDFE
287
LLDGIDCTLQ
303
FLAAPICLLY
313
KNLANKIVPI
323

AIQLNQIPGD
333
ENPIFLPSDA
343
KYDWLLAKIW
353
VRSSDFHVHQ
363
TITHLLRTHL
373

VSEVFGIAMY
383
RQLPAVHPIF
393
KLLVAHVRFT
403
IAINTKAREQ
413
GGHVQMVQRA
439

MKDLTYASLC
449
FPEAIKARGM
459
ESKEDIPYYF
469
YRDDGLLVWE
479
AIRTFTAEVV
489

DIYYEGDQVV
499
EEDPELQDFV
509
NDVYVYGMRG
519
RKSSGFPKSV
529
KSREQLSEYL
539

TVVIFTASAQ
549
HAAVNFGQYD
559
WASWIPNAPP
569
TMRAPPPTAK
579
GVVTIEQIVD
589

TLPDRGRSCW
599
HLGAVWALSQ
609
FELFLGMYPE
622
EHFIEKPVKE
632
AMARFRKNLE
642

AIVSVIAERN
652
ENLQLPYYYL
662
DPDRIPNSVA
672
Residue
Distance (Å)
PHE169
4.382
SER171
2.844
PHE177
2.646
LEU179
4.831
PHE359
4.642
GLN363
2.719
HIS367
3.491
Residue
Distance (Å)
HIS372
4.043
ILE406
3.317
ASN554
3.969
GLN557
3.612
ALA603
4.700
LEU607
2.872
ALA672
4.292
Click to View More Binding Site Information of This Target with Different Ligands
Different Human System Profiles of Target  Top
Human Similarity Proteins of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs (Brief Bioinform, 21: 649-662, 2020).
Human Tissue Distribution of target is determined from a proteomics study that quantified more than 12,000 genes across 32 normal human tissues. Tissue Specificity (TS) score was used to define the enrichment of target across tissues.
The distribution of targets among different tissues or organs need to be taken into consideration when assessing the target druggability, as it is generally accepted that the wider the target distribution, the greater the concern over potential adverse effects (Nat Rev Drug Discov, 20: 64-81, 2021).
Human Pathway Affiliation of target is determined by the life-essential pathways provided on KEGG database. The target-affiliated pathways were defined based on the following two criteria (a) the pathways of the studied target should be life-essential for both healthy individuals and patients, and (b) the studied target should occupy an upstream position in the pathways and therefore had the ability to regulate biological function.
Targets involved in a fewer pathways have greater likelihood to be successfully developed, while those associated with more human pathways increase the chance of undesirable interferences with other human processes (Pharmacol Rev, 58: 259-279, 2006).
Biological Network Descriptors of target is determined based on a human protein-protein interactions (PPI) network consisting of 9,309 proteins and 52,713 PPIs, which were with a high confidence score of ≥ 0.95 collected from STRING database.
The network properties of targets based on protein-protein interactions (PPIs) have been widely adopted for the assessment of target’s druggability. Proteins with high node degree tend to have a high impact on network function through multiple interactions, while proteins with high betweenness centrality are regarded to be central for communication in interaction networks and regulate the flow of signaling information (Front Pharmacol, 9, 1245, 2018; Curr Opin Struct Biol. 44:134-142, 2017).
Human Similarity Proteins
Human Tissue Distribution
Human Pathway Affiliation
Biological Network Descriptors
There is no similarity protein (E value < 0.005) for this target
Note: If a protein has TS (tissue specficity) scores at least in one tissue >= 2.5, this protein is called tissue-enriched (including tissue-enriched-but-not-specific and tissue-specific). In the plots, the vertical lines are at thresholds 2.5 and 4.
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
KEGG Pathway Pathway ID Affiliated Target Pathway Map
Arachidonic acid metabolism hsa00590 Affiliated Target
  Class: Metabolism => Lipid metabolism Pathway Hierarchy
Fc epsilon RI signaling pathway hsa04664 Affiliated Target
  Class: Organismal Systems => Immune system Pathway Hierarchy
Serotonergic synapse hsa04726 Affiliated Target
  Class: Organismal Systems => Nervous system Pathway Hierarchy
Ovarian steroidogenesis hsa04913 Affiliated Target
  Class: Organismal Systems => Endocrine system Pathway Hierarchy
Degree 7 Degree centrality 7.52E-04 Betweenness centrality 8.13E-04
Closeness centrality 1.93E-01 Radiality 1.33E+01 Clustering coefficient 4.76E-02
Neighborhood connectivity 4.71E+00 Topological coefficient 2.11E-01 Eccentricity 13
Download Click to Download the Full PPI Network of This Target

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.